AzTrials
AzTrials

Sleep DeprivationSHH: Noise!NCT03774212

Sleep Headphones and HDU: a Novel Intervention and Sound Evaluation

A study testing Active noise cancelling headphones in people with Sleep Deprivation and Sleep, run by University of Edinburgh at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is well established that patients sleep poorly in the Intensive Care Unit (ICU), and excessive noise is considered to be a modifiable cause of this. Previous studies have tried to reduce ambient noise by educating staff and fixing noisy equipment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sleep Deprivation, Sleep
What is being tested?
Active noise cancelling headphones
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited Kingdom
Study dates
5 Feb 2019to 1 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Critical care patient in Royal Infirmary of Edinburgh

Who cannot join

  • < 18 years of age
  • If the patient is delirious. This will be clarified by asking the nurses, who use the Confusion Assessment method for the ICU (CAM-ICU) Score.
  • If the patient is receiving any form of ventilation (invasive or non-invasive ventilation, continuous positive airway pressure (CPAP), High flow nasal oxygen (HFNO) or respiratory support at night)
  • Physical reasons why they can't wear over-ear headphones
  • Pre-existing severe hearing impairment
  • Previous participation in the study.
Show all 9Show fewer
  • If the patient is likely to receive medical interventions during the night that would disturb their sleep.
  • Patients expected to leave the critical care wards within the following 48hours.
  • Refusing consent or inability to give consent.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SA

Other trials in United Kingdom

About this study

Official title: Do Active Noise Cancelling Headphones With White Noise Masking Improve Sleep in Non-ventilated, Non-delirious Critical Care Patients?

It is well established that patients sleep poorly in the Intensive Care Unit (ICU), and excessive noise is considered to be a modifiable cause of this. Previous studies have tried to reduce ambient noise by educating staff and fixing noisy equipment. Other studies have tried to reduce the noise experienced by patients by supplying them with active noise cancelling headphones and earplugs. In this study we are combining Active Noise Cancelling headphones with white noise to try and reduce noise experienced by patients, with the aim of improving their sleep. Sleep deprivation is known to negatively impact health, and so improving sleep may improve patient outcomes as well as improve the patient's experience in critical care.

The Investigators will screen all patients in the critical care wards in the Royal Infirmary of Edinburgh. Patients that are receiving ventilation, are delirious or have already been enrolled in the study will be excluded. After allowing patients to give informed consent, we will randomise them into one of two study groups:

Read more

Study group A will receive standard care on the 1st night (no headphones), and will receive the intervention (active noise cancelling headphones with white noise) on the 2nd night.

Study group B will receive the intervention on the 1st night, and will receive standard care on the 2nd night.

All patients will wear a Xiaomi MiBand 2 wrist band, that tracks movement and sleep.

Patients will fill in the Pittsburgh Sleep Quality Index at the beginning of the study to establish usual sleeping habits.

Our primary outcome measure is the mean score on the Richard Campbell Sleep Questionnaire (RCSQ), which will be filled in by the patient the morning after each night.

Our secondary outcome measure is the data from the wrist band, noise levels measured overnight, and patient experience of the intervention.

Being tested
Active noise cancelling headphones
Keywords
Critical care patients, High dependency unit, Intensive care unit
Medical subject headings
Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active noise cancelling headphonesDevice

    Also called White noise masking

    The white noise will play from an 'iPod touch' (Apple), through the active noise cancelling headphones.

Study groups in NCT03774212
Study groupRoleWhat they receive
Group AExperimentalOn study night 1, participants will receive standard care (no headphones provided). On study night 2, these patients will wear Active Noise Cancelling headphones playing white noise.
Receives: Device: Active noise cancelling headphones
Group BExperimentalPatients will spend night 1 wearing Active Noise Cancelling headphones playing white noise. On Study night 2, these patients will receive standard care (no headphones provided).
Receives: Device: Active noise cancelling headphones

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in score on the Richards-Campbell sleep questionnaire.

    Richards-Campbell sleep questionnaire is a series of 5 Visual analog scales that are 100mm long, and range from "best possible" to "worst possible". The final result is calculated by taking a mean of the distances along each line (from left to right).

    Measured: Day 1 and day 2 after participant's enrolment. Completed throughout the 6 month study duration.

Secondary outcomes (2)
  1. Patient experience

    Patients will fill out a questionnaire about their experience. Participants will be required to circle an appropriate descriptive word to answer each question.

    Measured: Day 2 after participant's enrolment. Completed throughout the 6 month study duration.

  2. Actigraphy data

    The wrist band provides:

    • Total sleep time
    • Deep sleep time
    • Light sleep Time

    Measured: Night 1 and 2 of participant's enrolment. Completed throughout the 6 month study duration.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2018
  2. Study start5 Feb 2019
  3. Primary completion18 Mar 2019
  4. Study completion1 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03774212
Sponsor's protocol ID
AC18134
Acronym
SHH: Noise!
Status last verified
Aug 2019
First submitted
7 Dec 2018
Last updated
12 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We will not be sharing individual participant data with other researchers

Questions about this trial

What is this clinical trial studying?

A study testing Active noise cancelling headphones in people with Sleep Deprivation and Sleep, run by University of Edinburgh at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in score on the Richards-Campbell sleep questionnaire. (time frame: Day 1 and day 2 after participant's enrolment. Completed throughout the 6 month study duration.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in